Combining Chinese herbal medicine formula with standard chemotherapy and Molecular Targeted Therapy in patients with metastatic colorectal cancer(mCRC): a multi-institutional, randomised, double-blinded, placebo controlled trial

ABSTRACT: Interventions: treatment group:Chemotherapy combined with targeted and HeZhongfang Granule);Placebo group:Chemotherapy combined with targeted agents and placebo (Granule) Primary outcome(s): Progression-free survival (PFS) Study Design: Parallel

DISEASE(S): Metastatic Colon Carcinoma

PROVIDER: 2701824 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR